Cargando…
SARS-CoV-2 vaccine challenge based on spike glycoprotein against several new variants
The coronavirus disease 2019 pandemic has not ended, and several variants of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus continue to emerge. The emergence of new variants is worrying because higher transmission leads to spikes in infections, vaccine efforts, and other ther...
Autores principales: | Syahniar, Rike, Kharisma, Dayu Swasti |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Vaccine Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9200648/ https://www.ncbi.nlm.nih.gov/pubmed/35799876 http://dx.doi.org/10.7774/cevr.2022.11.2.173 |
Ejemplares similares
-
Are the COVID-19’s vaccines efficient on the most dangerous variant of SARS-CoV-2?
por: Davoodi, Poorya, et al.
Publicado: (2021) -
Clinical severity according to the primary infection variant in patients with suspected SARS-CoV-2 reinfection in Korea
por: Hwang, Myung-Jae, et al.
Publicado: (2022) -
Involvement of Spike Protein, Furin, and ACE2 in SARS-CoV-2-Related Cardiovascular Complications
por: Ming, Yi, et al.
Publicado: (2020) -
Severe SARS-CoV-2 disease in the context of a NF-κB2 loss-of-function pathogenic variant
por: Abraham, Roshini S., et al.
Publicado: (2021) -
Infections sévères à SARS-CoV-2
por: Taghboulit, N., et al.
Publicado: (2021)